BVMF/I1NC34 (BVMF/I1NC34)

Brazil Stock Exchange: BVMF/I1NC34 · BRL

R$316

+6.58 (+2.1%)· Recorded snapshot

Market cap	128.1B
Revenue (ttm)	31.1B
Net income (ttm)	2.1B
EPS (ttm)	R$5.23
P/E (trailing)	60.3x
P/E (forward)	14.8x
Volume	177

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 31.1B
Net income (ttm): 2.1B
EPS (ttm): R$5.23
P/E (trailing): 60.3x
P/E (forward): 14.8x
Market cap: 128.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E14.8

P25 n/aP50 n/aP75 n/a

Trailing P/E60.3

P25 n/aP50 n/aP75 n/a

ROE7.8

P25 n/aP50 n/aP75 n/a

ROIC19.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/I1NC34 indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

USD

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-29
Employees	2,844
Employees change	227
Employees growth	8.67%
Enterprise value	BRL 107.5B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1991
Industry	Biotechnology
Is primary listing	No
ISIN number	BRI1NCBDR004
Last earnings date	2026-10-29
Last refreshed	2026-10-30
Market cap	BRL 128.1B
Next earnings date	2027-02-09
Price	BRL 315.88
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bvmf/I1NC34
Website	https://www.incyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	87.74x
Average P/E ratio (3Y)	138.66x
Average P/E ratio (5Y)	95.25x
Earnings yield	1.66%
EV/Earnings	51.42x
EV/EBIT	28.17x
EV/EBITDA	24.52x
EV/FCF	10.39x
EV/Sales	3.3x
FCF / EV yield	9.62%
FCF yield	8.07%
Forward P/E	14.82x
Graham number	91.38429
Graham upside	-71.07%
Lynch fair value	BRL 25.76
Lynch upside	-91.85%
P/(FCF - SBC) ratio	14.29x
P/(OCF - SBC) ratio	13.8x
P/B ratio	4.38x
P/E ratio	60.35x
P/FCF ratio	12.39x
P/OCF ratio	12.02x
P/S ratio	4.12x
Price / tangible book value	4.58x
Price/EBITDA ratio	30.61x
Sector forward P/E	10.79x
Sector P/E	32.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	11.72%
EBITDA margin	13.44%
Effective tax rate	49.33%
FCF margin	33%
Gross margin	58.58%
Operating margin	11.72%
Pretax margin	13.25%
Profit margin	6.71%
Profit per employee	BRL 734,750
Profitable quarters	8
Profitable years	5
Revenue per employee	BRL 10.9M
ROA	6.47%
ROA (5Y)	7.33%
ROCE	12.22%
ROE	7.84%
ROE (5Y)	16.25%
ROIC	19.47%
ROIC (5Y)	36.75%
SBC / revenue	4.38%
Tax / revenue	6.53%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-67.07%
EPS growth 10Y	10.08%
EPS growth 3Y	1.07%
EPS growth 5Y	-4.22%
EPS growth quarters	7
EPS growth years	1
FCF growth	100.45%
FCF growth 3Y	39.16%
FCF growth 5Y	33.68%
Gross profit growth	37.07%
Gross profit growth (Q)	90.49%
Gross profit growth 3Y	27.92%
Gross profit growth 5Y	21.38%
Net income growth	-66.06%
Net income growth 3Y	-1.72%
Net income growth 5Y	-5.47%
Net income growth quarters	5
Net income growth years	1
OCF growth	97.4%
OCF growth 10Y	26.22%
OCF growth 3Y	36.35%
OCF growth 5Y	24.25%
Operating income growth	-44.06%
Operating income growth 3Y	8.97%
Operating income growth 5Y	1.48%
Revenue growth	24.88%
Revenue growth (Q)	14%
Revenue growth (QoQ)	-6.98%
Revenue growth 10Y	19.37%
Revenue growth 3Y	18.54%
Revenue growth 5Y	15.59%
Revenue growth quarters	33
Revenue growth years	14

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -319M
Depreciation and amortization	BRL 556.8M
EBIT	BRL 3.7B
EBITDA	BRL 4.2B
EPS	BRL 5.23
Financing cash flow	BRL 1.5B
Free cash flow	BRL 10.3B
Free cash flow minus SBC	BRL 9B
Gross profit	BRL 18.2B
Income taxes	BRL 2B
Investing cash flow	BRL -1.2B
Net borrowing	BRL -25M
Net cash flow	BRL 10.9B
Net income	BRL 2.1B
Operating cash flow minus SBC	BRL 9.3B
Operating income	BRL 3.7B
Revenue	BRL 31.1B
Stock-based compensation	BRL 1.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BRL 143.82
Debt / EBITDA	0.04
Debt / equity	0.01
Debt / FCF	0.02
Goodwill	BRL 716.2M
Interest coverage	301.41
Long-term assets	BRL 5.7B
Long-term liabilities	BRL 329.5M
Net cash (debt)	BRL 19.8B
Net cash / market cap	15.45%
Net cash growth	32.34%
Net debt / EBITDA	-4.73
Net debt / equity	-0.68
Net debt / FCF	-1.91
Piotroski F-Score	7
Property, plant and equipment	BRL 3.9B
Shareholders' equity	BRL 29.2B
Tangible book value	BRL 28B
Tangible book value per share	BRL 137.79
Total assets	BRL 37.7B
Total cash	BRL 20B
Total debt	BRL 164.5M
Total liabilities	BRL 8.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.88
Current assets	BRL 32.1B
Current liabilities	BRL 8.2B
Current ratio	3.91
Inventory turnover	8.9
Net working capital	BRL 3B
Quick ratio	3.35
Working capital	BRL 23B
Working capital turnover	8.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.21%
Shareholder yield	-3.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 252.97
1D price change	2.13%
1M price change	-3.02%
1M total return	-3.02%
1W price change	9.58%
1W total return	9.58%
1Y price change	27.91%
1Y return CAGR	27.93%
1Y total return	27.91%
20-day SMA	BRL 305.43
200-day SMA	BRL 236.36
3M price change	7.08%
3M total return	7.08%
3Y price change	97.4%
3Y return CAGR	25.44%
3Y total return	97.4%
50-day SMA	BRL 275.17
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 328.68
52-week high date	2026-08-24
52-week low	BRL 232.56
52-week low date	2026-05-26
5Y price change	71.21%
5Y return CAGR	11.36%
5Y total return	71.21%
6M price change	33.76%
6M total return	33.76%
All-time high	BRL 328.68
All-time high date	2026-08-21
All-time low	BRL 135.90
All-time low date	2024-04-22
Average true range (ATR)	BRL 8.61
Average volume	278.9
Change from 52-week high	-3.89%
Change from 52-week low	35.83%
Change from all-time high	-3.89%
Change from all-time low	132.44%
Change from open	0%
Day's gap	2.13%
Dollar volume	BRL 55,911
High price	BRL 315.88
Low price	BRL 315.88
Monthly RSI	67.08
Open price	BRL 315.88
Previous close	BRL 309.30
Price vs 150-day SMA	24.87%
Price vs 20-day SMA	3.42%
Price vs 200-day SMA	33.64%
Price vs 50-day SMA	14.79%
Relative volume	0.63
RSI	59.73
Sharpe ratio	0.6
Sortino ratio	1.12
Volume	177
Weekly RSI	61.22
YTD price change	14%
YTD total return	14%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	170.4M
Shares change (QoQ)	-2.39%
Shares change (YoY)	3.21%
Shares held by insiders	0.46%
Shares held by institutions	87.82%

Deeper analysis on BVMF/I1NC34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/I1NC34 report

Is a complete BVMF/I1NC34 research report available?

No complete published report is available for bvmf/I1NC34 (BVMF/I1NC34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/I1NC34 (BVMF/I1NC34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/I1NC34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/I1NC34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/I1NC34

Frequently asked questions